User:Suriname0/NeuroVista trial

The NeuroVista trial was a brain implant trial for treating epilepsy. Corporation was founded in 2002 by Dr. Leonidas Iasemidis and Dr. Daniel DiLorenzo as an early-stage medical device company that specialized in the management and treatment of epilepsy, including a novel Seizure Advisory System.

Based in Seattle, Washington, NeuroVista was previously known as NeuroBionics Corporation, and subsequently went through six rounds of financing totaling $61.3M USD.

In 2010, Cyberonics announced that it had entered into technology agreements with NeuroVista.

NeuroVista shut down operations in 2013.

15 participants